RESEARCH TRIANGLE PARK, NC - October 30, 1996 - Quintiles Transnational Corp. (Nasdaq: QTRN) announced today two appointments to executive positions.
Effective December 1, Ludo J. Reynders has been named Chief Executive Officer of the Quintiles Contract Research Organization (CRO) division. Reynders, 43, who previously served as the head of Quintiles' European operations, will be responsible for the company's worldwide full-service CRO operations. This division encompasses more than 40 offices in 20 countries and includes about 2,900 people. Reynders will report to Santo J. Costa, President and Chief Operating Officer of Quintiles Transnational Corp., and will continue to be based in Bracknell, U.K. for the foreseeable future.
Quintiles has announced that effective December 1, James T. Ogle will be named President, Quintiles Americas upon the completion of Quintiles' acquisition of BRI. The Americas region, one of three regions in Quintiles' Contract Research Organization (CRO) division, is composed of eight offices in the United States, Canada, and Latin America and includes about 1,300 people. Ogle, 52, is President and CEO of BRI, an international contract research and medical device business. Ogle will report to Ludo Reynders, the newly named head of Quintiles' Contract Research Organization division, and will be based at Research Triangle Park, N.C. Ogle will replace William Sollecito who is retiring December 31 and will be pursuing his academic interests. Sollecito will act as a consultant to Quintiles.
Quintiles provides healthcare product development and information management services worldwide to governments and the pharmaceutical, biotechnology and medical device industries. Quintiles' globally integrated services include clinical research and data management, and consulting on healthcare policy, health management and regulatory issues. Quintiles is headquartered near Research Triangle Park, N.C., and has 43 operating units in 20 countries.